In the M-ACCEL trial, HU6-induced weight loss was exclusively attributed to fat loss, with no statistically significant loss ...

Results of two phase 2 studies suggest efgartigimod could be a potential treatment for myositis and Sjögren disease in ...

Use of an investigational monoclonal antibody called bimagrumab added to semaglutide produced weight loss while preserving muscle mass.

Nipocalimab's FDA approval revolutionizes generalized myasthenia gravis treatment, offering rapid symptom relief and improved ...

PST-611-CT1 is a first-in-human single ascending dose study that aims to establish, in six to a maximum of 12 dry AMD/GA patients, the safety profile of the drug and validate the maximal tolerated ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Approval of Zusduri was based on data from the Phase III ENVISION trial, which showed a 78% complete response at three months in patients with recurrent low-grade, intermediate-risk non-muscle ...

Unlock serious lower body power by training the muscle group most lifters ignore. Add these adductor movements to your routine to build strength, prevent injury, and level up performance with the Mast ...

Other high-profile ... that muscle is going to be weaker and it can't handle high-end stress as well." Q: Could painkillers be masking warning signs? The use of anti-inflammatories like strong ...

According to information gathered by 90min, Al-Nassr have set their sights on Flamengo midfielder Gerson as a priority target ...

An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year ...

Buckle posted on Instagram between June 23 and June 26 to share each step of his plastic surgery experience, down to the surgeon he tapped to work on his face. He also gave a look at the healing ...